Showing results (111-120 of 402) with videos related to

Sort By:
Pageof 41
Oncology|July 16, 2005
Weekly docetaxel in pretreated metastatic breast cancer patients: a phase I-II studyCecilia Nisticò, Francesco Cognetti, Luciano Frontini, et al.
Critical Reviews in Oncology/Hematology|June 6, 2022
Effect of exercise on functional capacity in patients with advanced cancer: A meta-analysis of randomized controlled trialsAlice Avancini, Isabella Sperduti, Anita Borsati, et al.
Cancer Medicine|February 17, 2026
Structured Exercise During Chemotherapy for Locally Advanced or Metastatic Pancreatic Cancer: A Single-Arm, Feasibility TrialAnita Borsati, Linda Toniolo, Gloria Adamoli, et al.
Heliyon|March 11, 2025
Combining a 9-month tailored physical exercise program with osimertinib and denosumab in a patient affected by advanced NSCLC with multiple osteolytic bone lesions: A case reportAnita Borsati, Christian Ciurnelli, Lorenzo Belluomini, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 15, 2023
Activated MKK3/MYC crosstalk impairs dabrafenib response in BRAFV600E colorectal cancer leading to resistanceAngelina Pranteda, Valentina Piastra, Martina Serra, et al.
Seminars in Oncology|October 2, 2022
Maintenance or consolidation therapy in small-cell lung cancer: an updated systematic review and meta-analysisLorenzo Belluomini, Sara Pilotto, Alice Avancini, et al.
Oncology|February 28, 2009
Capecitabine and celecoxib as second-line treatment of advanced pancreatic and biliary tract cancersMaria S Pino, Michele Milella, Alain Gelibter, et al.
Critical Reviews in Oncology/Hematology|September 18, 2016
Presurgical window of opportunity trial design as a platform for testing anticancer drugs: Pros, cons and a focus on breast cancerMarcello Maugeri-Saccà, Maddalena Barba, Patrizia Vici, et al.
International Journal of Cancer|February 8, 2013
Prognostic factors in gemcitabine-cisplatin polychemotherapy regimens in pancreatic cancer: XPD-Lys751Gln polymorphism strikes backAmir Avan, Paola Pacetti, Michele Reni, et al.
Plos One|April 3, 2020
"Running with cancer": A qualitative study to evaluate barriers and motivations in running for female oncological patientsAlice Avancini, Kristina Skroce, Daniela Tregnago, et al.
Pageof 41